Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen. (Q46966228)
Jump to navigation
Jump to search
scientific article published on 4 October 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen. |
scientific article published on 4 October 2007 |
Statements
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen (English)
M Buxton
N R Poulter
B Dahlöf
P S Sever
H Wedel
B Jönsson
ASCOT trial investigators